Also known as: Chromium picolinate, Chromium polynicotinate
Latest evidence update: 2026-06-17
Outcome estimates are derived from published research and represent population-level associations, not guaranteed individual results. Consult a healthcare professional before making decisions based on these estimates.
Recommended: Varies by form and individual needs
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.
Reduces insulin levels and insulin resistance in people with overweight, obesity, type 2 diabetes, and polycystic ovary syndrome
May produce modest weight loss in overweight and obese individuals, though clinical significance remains uncertain
Reduces inflammation markers and blood triglycerides in women with polycystic ovary syndrome
Lowers blood pressure slightly, particularly with certain chromium forms and in people with diabetes and heart disease
Reduces triglyceride levels in people with diabetes at higher doses